Chrome Extension
WeChat Mini Program
Use on ChatGLM

A phase I dose escalation and expansion study of HPN424, a PSMA-targeting T cell engager, in patients with advanced prostate cancer refractory to androgen therapy

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2019)

Cited 0|Views26
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined